Risk category | Risk group | Diarrhoea | Vomiting | ||||||
---|---|---|---|---|---|---|---|---|---|
 |  | AL | DP | AL | DP | ||||
 |  | HR†(95% CI) | p-value | HR†(95% CI) | p-value | HR†(95% CI) | p-value | HR†(95% CI) | p-value |
Age | >15-22 months | 1.0 (reference) | - | 1.0 (reference) | - | 1.0 (reference) | - | 1.0 (reference) | - |
 | >12-15 months | 1.17 (0.56-2.46) | 0.67 | 3.34 (1.39-8.02) | 0.007 | 0.75 (0.10-5.58) | 0.78 | 2.66 (0.80-8.85) | 0.11 |
 | >10-12 months | 2.04 (1.09-3.85) | 0.03 | 4.03 (1.90-8.53) | < 0.001 | 0.32 (0.04-2.86) | 0.31 | 2.61 (0.66-10.3) | 0.17 |
 | 4-10 months | 2.11 (1.09-4.08) | 0.03 | 3.22 (1.33-7.81) | 0.01 | 1.14 (0.30-4.27) | 0.84 | 1.08 (0.20-5.90) | 0.93 |
Duration since last treatment | > 63 days or no prior treatment | 1.0 (reference) | - | 1.0 (reference) | - | 1.0 (reference) | - | 1.0 (reference) | - |
 | 28-63 days | 0.54 (0.34-0.86) | 0.009 | 0.85 (0.47-1.52) | 0.57 | 0.77 (0.24-2.42) | 0.65 | 0.78 (0.30-2.02) | 0.60 |
 | 17-28 days | 0.68 (0.36-1.29) | 0.24 | 1.33 (0.47-3.73) | 0.59 | 0.71 (0.11-4.73) | 0.72 | 6.63 (2.33-18.9) | < 0.001 |
HIV status, | HIV-uninfected not taking TS | 1.0 (reference) | - | 1.0 (reference) | - | 1.0 (reference) | - | 1.0 (reference) | - |
TS use, | HIV-uninfected taking TS | 0.78 (0.47-1.28) | 0.32 | 1.26 (0.76-2.11) | 0.37 | 1.04 (0.27-4.02) | 0.95 | 1.30 (0.47-3.55) | 0.62 |
ARV use* | HIV-infected taking TS and ARVs | 0.33 (0.12-0.90) | 0.03 | 0.46 (0.11-2.03) | 0.31 | 1.77 (0.20-15.7) | 0.61 | 1.85 (0.31-10.9) | 0.50 |